Inhibition of allergic reactions by cromoglycate and by a new series of compounds (AH 6556, AH 7079 and AH 7725).
D002264:Carboxylic Acids / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004140:Dinitrophenols; D006632:Histamine / Q000096:biosynthesis; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000517:prevention & control*; D007106:Immune Sera; D007073:Immunoglobulin E; D007962:Leukocytes / Q000276:immunology; D008168:Lung / Q000276:immunology; D008213:Lymphocyte Activation; D008407:Mast Cells / Q000276:immunology; D008738:Methyl Ethers / Q000627:therapeutic use; D008925:Mites; D014688:Venoms; D014966:Xanthenes / Q000627:therapeutic use*; D044004:Xanthones
D002264:Carboxylic Acids; D004140:Dinitrophenols; D006634:Histamine H1 Antagonists; D007106:Immune Sera; D008738:Methyl Ethers; D014688:Venoms; D014966:Xanthenes; D044004:Xanthones; C006205:2-carboxy-7-methoxyxanthen-9-one; D007073:Immunoglobulin E; D006632:Histamine; D004205:Cromolyn Sodium